# A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC

> **NCT06823050** · — · NOT_YET_RECRUITING · sponsor: **Xuhua Duan** · enrollment: 59 (estimated)

## Conditions studied

- Hepatocellular Carcinoma

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT06823050
- **Lead sponsor:** Xuhua Duan
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-03-01
- **Final completion:** 2028-02-28
- **Target enrollment:** 59 (ESTIMATED)
- **Last updated:** 2025-02-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06823050

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06823050, "A Prospective, Multicenter, Phase II Clinical Study on the Treatment of Unresectable Advanced HCC with DEB-TACE Combined with SALOX-HAIC". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06823050. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*